Using tetrahydrocurcumin and doxorubicin-loaded transferrin-conjugated nanoparticles caused a significantly larger cytotoxic effect than treatment with doxorubicin-loaded nanoparticles alone in glioma cells. This evidence concerns the gene TF and glioma.